MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2001-12-0371PMID 12130511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

  2002cited by this paper
• Expression of functional lung resistance--related protein predicts poor outcome in adult T-cell leukemia.

  2001cited by this paper
• Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.

  2000cited by this paper
• A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia.

  2000cited by this paper
• Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

  1999cited by this paper
• Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.

  1999cited by this paper
• P‐glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6‐year prospective study

  1999cited by this paper
• Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.

  1999cited by this paper
• Resistance to chemotherapy in acute leukemia

  1998cited by this paper
• The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

  1998cited by this paper
• Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

  1998cited by this paper
• MDR1 gene expression and drug resistance of AML cells

  1998influential reference
• Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin

  1998cited by this paper
• Non-P-glycoprotein drug export mechanisms of multidrug resistance.

  1997cited by this paper
• Measuring multidrug resistance expression in human malignancies: elaboration of consensus recommendations.

  1997influential reference
• Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients

  1997influential reference
• Mechanisms of drug resistance in hematologic malignancies.

  1997cited by this paper
• Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia

  1997cited by this paper
• Multicentric evaluation of the MDR phenotype in leukemia

  1997cited by this paper
• Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.

  1997cited by this paper
• Verapamil suppresses the emergence of P‐glycoprotein‐mediated multi‐drug resistance

  1996cited by this paper
• Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.

  1996cited by this paper
• Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

  1996influential reference
• Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia.

  1996influential reference
• Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.

  1995cited by this paper
• A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

  1995cited by this paper
• The drug resistance-related protein LRP is the human major vault protein

  1995cited by this paper
• The biology and treatment of acute lymphoblastic leukemia in adults.

  1995cited by this paper
• Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia.

  1995cited by this paper
• Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.

  1994cited by this paper
• Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia.

  1994cited by this paper
• Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.

  1993cited by this paper
• A Southwest Oncology Group study

  1993cited by this paper
• Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.

  1993cited by this paper
• The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia.

  1993cited by this paper
• Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).

  1992cited by this paper
• Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.

  1992cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity.

  1991influential reference
• Expression of P-glycoprotein in adult T-cell leukemia cells.

  1990cited by this paper
• Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.

  1990cited by this paper
• Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia.

  1989cited by this paper
• Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

  1988cited by this paper
• Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins.

  1986influential reference
• Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients.

  1982cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• MAPK/ERK and PI3K/AKT signaling pathways are activated in adolescent and adult acute lymphoblastic leukemia

  2023cites this paper
• Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia

  2022cites this paper
• Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia

  2020cites this paper
• Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial

  2020cites this paper
• P‐glycoprotein and multidrug resistance‐associated protein‐1 expression in acute myeloid leukemia: Biological and prognosis implications

  2020cites this paper
• Induction of autophagy, apoptosis and aquisition of resistance in response to piceatannol toxicity in MOLT-4 human leukemia cells.

  2019cites this paper
• Expression of the MDRI Gene and Lines P-Glycoproteinin Canine Mast Cell Tumor Cell

  2018cites this paper
• P-glycoprotein Activity Correlates With Treatment Response in 2 Leukemia Child Patients

  2018cites this paper
• Multidrug resistance gene 1 polymorphisms in pediatric patients with leukemia at a national referral hospital in Indonesia

  2017cites this paper
• Role of P-Glycoprotein for Resistance of Tumors to Anticancer Drugs: From Bench to Bedside

  2015cites this paper
• Overexpression of EPS8 is associated with poor prognosis in patients with acute lymphoblastic leukemia.

  2015cites this paper
• Agents for refractory/relapsed acute lymphocytic leukemia in adults.

  2014cites this paper
• Nilotinib Enhances the Efficacy of Conventional Chemotherapeutic Drugs in CD34+CD38− Stem Cells and ABC Transporter Overexpressing Leukemia Cells

  2014cites this paper
• mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2

  2014cites this paper
• Estudo da Associação de Genes e Proteínas de Resistência a Múltiplos Fármacos (abcb1/ABCB1, abcc1/ABCC1 e lrp/LRP) com Marcadores Moleculares em Pacientes Portadores de Leucemias Agudas

  2013cites this paper
• resistance Active transport of imatinib into and out of cells: implications for drug

  2013cites this paper
• remission in newly diagnosed adult acute lymphoblastic leukemia ERK1/2 phosphorylation is an independent predictor of complete

  2013cites this paper
• Monoclonal antibody therapy of adult acute lymphoblastic leukemia: progress and challenge for new clinical trials

  2013cites this paper
• patients enrolled in the GIMEMA LAL 0496 protocol presentation and correlation with response to induction treatment in Adult T-cell acute lymphoblastic leukemia: biologic profile at

  2013cites this paper
• Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia.

  2013cites this paper
• Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.

  2012cites this paper
• Foetal Haemoglobin, Erythrocytes Containing Foetal Haemoglobin, and Hematological Features in Congolese Patients with Sickle Cell Anaemia

  2012cites this paper
• Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation

  2012influential citation
• The Treatment of Adult Acute Lymphoblastic Leukemia (ALL): Risk Stratification and Strategies

  2012cites this paper
• Biochemistry and Pharmacology of Human ABCC1/MRP1 and Its Role in Detoxification and in Multidrug Resistance of Cancer Chemotherapy

  2012cites this paper
• Modern therapy of acute lymphoblastic leukemia.

  2011cites this paper
• Expression of P-glycoprotein, Cyclin D1 and Ki-67 in Acute Lymphoblastic Leukemia: Relation with Induction Chemotherapy and Overall Survival

  2011cites this paper
• Aberrant Proliferative and Apoptotic Pathways in Acute Lymphoblastic Leukemia (ALL): Molecular Therapies to Overcome Chemo-Resistance

  2011cites this paper
• Revisiting the ABCs of multidrug resistance in cancer chemotherapy.

  2011cites this paper
• Terapia mirata dell'asse di pi3k/akt/mtor come possibile nuova strategia terapeutica nel trattamento delle leucemie linfoblastiche acute T

  2010cites this paper
• Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia

  2010cites this paper
• Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia

  2010cites this paper
• Association between MDR1 C3435T Gene Polymorphism and Acute Lymphoblastic Leukemia (ALL) in Iranian Population

  2010cites this paper
• Untersuchungen zur Molekulargenetik der akuten lymphatischen Leukämie des Erwachsenenalters

  2010cites this paper
• acute lymphoblastic leukemia Expression of lung resistance protein and multidrug resistance-related protein ( MRP 1 ) in pediatric

  2010cites this paper
• Mechanisms of multidrug resistance in cancer.

  2010cites this paper
• New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia

  2009cites this paper
• Association of Acute Lymphoblastic Leukemia and MDR1 Gene Polymorphism in an Ethnic Iranian Population

  2009cites this paper
• New targets for Ph+ leukaemia therapy.

  2009cites this paper
• 66 The Hepatocyte and the

  2009cites this paper
• Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.

  2009cites this paper
• Expression of ABCC-Type Nucleotide Exporters in Blasts of Adult Acute Myeloid Leukemia: Relation to Long-term Survival

  2009cites this paper
• Looking toward the future: novel strategies based on molecular pathogenesis of acute lymphoblastic leukemia.

  2009cites this paper
• Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids.

  2008cites this paper
• Detection and clinical significance of multidrug resistance-1 mRNA in bone marrow cells in children with acute lymphoblastic leukemia by real-time fluorescence quantitative RT-PCR

  2008cites this paper
• Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor , A 443654 , in T-Acute Lymphoblastic Leukemia

  2008cites this paper
• Proapoptotic Activity and Chemosensitizing Effect of the Novel Akt Inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-Cell Acute Lymphoblastic Leukemia

  2008cites this paper
• Multidrug resistance-1 in T lymphocytes and natural killer cells of adults with idiopathic thrombocytopenic purpura: effect of prednisone treatment.

  2008cites this paper
• MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.

  2008cites this paper
• CD34 expression is associated with poor survival in pediatric T‐cell acute lymphoblastic leukemia

  2008cites this paper
• The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism

  2008cites this paper
• ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?

  2007cites this paper
• Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.

  2007cites this paper
• Expression of the MDR1 gene and P-glycoprotein in canine mast cell tumor cell lines.

  2007cites this paper
• Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice.

  2007cites this paper
• Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

  2007cites this paper
• ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.

  2007cites this paper
• Expression of Multidrug Resistance 1 (MDR1), Multidrug Resistance-Related Protein 1 (MRP1), Lung Resistance Protein (LRP), and Breast Cancer Resistance Protein (BCRP) Genes and Clinical Outcome in Childhood Acute Lymphoblastic Leukemia

  2007cites this paper
• Genetic alterations determine chemotherapy resistance in childhood T‐ALL: modelling in stage‐specific cell lines and correlation with diagnostic patient samples

  2007cites this paper
• Chemotherapy-induced resistance by ATP-binding cassette transporter genes.

  2007cites this paper
• Modulation of P-glycoprotein by zosuquidar trihydrochloride.

  2007cites this paper
• P-Glycoprotein (P-170) expression in acute leukemias

  2006cites this paper
• Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia

  2006cites this paper
• Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.

  2006cites this paper
• Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia

  2006cites this paper
• Mécanismes de résistance aux agents cytostatiques

  2006cites this paper
• Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia.

  2006cites this paper
• Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia

  2006cites this paper
• Genes of multidrug resistance in haematological malignancies

  2006cites this paper
• The changing scene of adult acute lymphoblastic leukemia

  2006cites this paper
• Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia.

  2006cites this paper
• Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance‐related proteins

  2006cites this paper
• Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity.

  2006cites this paper
• DualChip® microarray as a new tool in cancer research

  2006cites this paper
• Plasma cell dyscrasias and leukemias.

  2006cites this paper
• Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia

  2006cites this paper
• A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.

  2005cites this paper
• Der Einfluss verschiedener Faktoren unter Berücksichtigung der Ausprägung des MDR1-Phänotypes bei Patienten mit akuter myeloischer Leukämie

  2005cites this paper
• Approaches to detect the drug resistance in acute leukemia

  2005cites this paper
• The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: A retrospective study of 295 newly diagnosed patients by the Children's Oncology Group

  2005cites this paper
• Treatment options in early stages of Hodgkin's Lymphoma, high cure rate with lower short and long-term toxicity

  2005cites this paper
• P-gp expression and Rh 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients.

  2005cites this paper
• Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patients

  2005cites this paper
• Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia.

  2005cites this paper
• Expression of Multidrug Resistance–Associated Proteins Predicts Prognosis in Childhood and Adult Acute Lymphoblastic Leukemia

  2005cites this paper
• Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.

  2005cites this paper
• A broad and integrated diagnostic work-up for a modern management of Acute Lymphoblastic Leukemia (ALL)

  2005cites this paper
• Vincristine resistance development in lymphoblastoid cells under conditions of selective P-glycoprotein inhibition

  2005cites this paper
• Daunorubicin efflux assay in determining multidrug resistance of patients with acute myeloid leukemia

  2005cites this paper
• Pharmacogenomics of MDR1/ABCB1 Gene: the Influence on Risk and Clinical Outcome of Haematological Malignancies

  2004cites this paper
• Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow.

  2004cites this paper
• Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?

  2004cites this paper
• Expression level of MDR1 message in peripheral blood leukocytes from healthy adults: a competitive nucleic acid sequence-based amplification assay for its determination

  2004cites this paper
• A competitive nucleic acid sequence-based amplification assay for the quantification of human MDR1 transcript in leukemia cells.

  2004cites this paper
• Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.

  2004cites this paper
• Assessment of drug resistance in acute myeloid leukemia

  2004cites this paper
• Molecular Pathways of Drug Resistance

  2004cites this paper
• Coexpression of p53 protein and MDR functional phenotype in leukemias: The predominant association in chronic myeloid leukemia

  2004cites this paper
• Adult acute lymphoblastic leukaemia.

  2004cites this paper
• Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia

  2004influential citation